Gene: PARP10
Official Full Name: poly(ADP-ribose) polymerase family member 10provided by HGNC
Gene Summary: Poly(ADP-ribose) polymerases (PARPs), such as PARP10, regulate gene transcription by altering chromatin organization by adding ADP-ribose to histones. PARPs can also function as transcriptional cofactors (Yu et al., 2005 [PubMed 15674325]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24575 | PARP10 Knockout cell line (HeLa) | Human | PARP10 | 1:3~1:6 | Negative | Online Inquiry |
PARP10 Gene Knockout Cell Lines are specialized tools developed for the study of the PARP10 gene and its implications in various cellular processes, including DNA repair, cell proliferation, and apoptosis. These cell lines are engineered to specifically disrupt the PARP10 gene, allowing researchers to investigate the biological effects of PARP10 loss in a controlled environment. The knockout mechanism utilizes CRISPR-Cas9 technology, which precisely edits the genome, creating a unique model system that aids in understanding gene function in health and disease.
The key function of these cell lines lies in their ability to elucidate the role of PARP10 in cellular pathways, particularly in relation to cancer biology and therapeutic resistance. By studying these knockout models, scientists can observe the phenotypic alterations and molecular changes that occur in the absence of PARP10, yielding insights that may not be possible with wild-type cell lines. This information is critical for developing targeted therapies and understanding tumorigenesis processes.
The scientific importance of PARP10 Gene Knockout Cell Lines extends into both basic research and clinical settings. In oncological studies, they offer a platform for researchers to explore PARP10's contribution to DNA damage response mechanisms, potentially linking to chemoresistance in tumors. Moreover, these models facilitate the identification of novel therapeutic targets, especially in the context of PARP inhibitors, which have revolutionized cancer treatment.
Moreover, these knockout cell lines present distinct advantages over existing alternatives, such as provided by traditional overexpression or knockdown approaches. They provide a complete and permanent gene disruption, allowing for the study of long-term effects associated with gene loss, thereby offering a more accurate representation of gene function in physiological settings.
For researchers and clinicians focusing on cancer biology and DNA repair mechanisms, our PARP10 Gene Knockout Cell Lines are invaluable tools that enhance experimental reliability and reproducibility. Their development represents a significant advance in the toolkit available for molecular and cellular biology studies.
Our company's expertise in genetic engineering and cell line development ensures that every product we offer is of the highest quality, rigorously validated, and tailored to meet the specific needs of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.